Products and Services

CDMO Aptuit, which provides inhaled drug development and clinical supply manufacturing services, will be acquired by German CRO Evotec for $300 million, the two companies have announced. Aptuit has about 750 employees at 3 sites in Italy, Switzerland, and the UK. In 2016, Aptuit acquired pre-clinical development specialist Kuecept, which also has extensive … [Read more...] about Aptuit to be acquired by Evotec

Lonza's acquisition of CDMO Capsugelfrom KKR for $5.5 billion, which was initially announced in December 2016, is now complete, the company said. In 2011, Pfizer sold Capsugel to KKR for just under $2.4 billion, and in 2013, Capsugel expanded its OINDP development and manufacturing services when it acquired Bend Research. The announcement stated that, "With … [Read more...] about Acquisition of Capsugel by Lonza completed

DPI device developer Iconovo AB announced that it has raised €.2.3 million in an oversubscribed share issue, which the company will use to fund expansion of its services to include drug formulation development. As part of that expansion, Iconovo has recently moved into larger facilities at the SmiLe Business Incubator in Medicon Village, Lund, Sweden, to support … [Read more...] about Iconovo adds drug formulation development services, signs deal with Amneal

Aptar Pharma has transferred manufacturing equipment for its Child-Resistant and Senior-Friendly Classic Nasal Pump from a plant in Germany to its facility in Congers, NY, the company said. According to Aptar, its child-resistant pump is used for every major brand of topical nasal decongestant spray marketed in the US. The child-resistant pump was developed in … [Read more...] about Aptar Pharma to manufacture child-resistant and senior-friendly nasal pumps in US

Device company Nemera has announced a partnership with the Research Center for Respiratory Diseases (CEPR) at the University of Tours for investigation of a novel intranasal drug delivery method. Nemera, which was formerly known as Rexam Healthcare Devices, markets the Advancia line of nasal spray pumps. The company recently announced that it would develop … [Read more...] about Nemera partners with the University of Tours for intranasal drug delivery research

Generic device company Merxin has announced the launch of its MRX003 dry powder inhaler, an off-the-shelf capsule based DPI intended for generic tiotropium 505j submissions. According to an announcement by Merxin's sister company Aedestra, the MRX003 DPI has the same design and features as the HandiHaler device, including the same air flow, same NGI profile, and … [Read more...] about Merxin launches generic capsule based DPI for tiotropium

Lactose manufacturer Meggle has announced the launch of InhaLac 500 micronized lactose for dry powder inhalation formulations, saying "Combined with high quality and safety, this material meets the most demanding individual dry powder inhalation formulation requirements." According to the company, 90% of the particles in InhaLac 500 are less than 10 µm in size, and … [Read more...] about Meggle launches InhaLac 500 micronized lactose for inhalation

Dalton Pharma Services will take responsibility for GMP preparation and filling into glass vials of Arch Biopartners' AB569 bactericidal inhalation solution for an upcoming Phase 1 trial, the companies have announced. Dalton will provide a range of services, including formulation development, method development and validation, and quality control release testing in … [Read more...] about Dalton Pharma Services announces development and manufacturing agreement with Arch Biopartners for AB569